Additionally, CATB (Cathepsin B) was previously reported as a potential candidate cancer biomarker in HCC [38], HPT (haptoglobin) was reported to associate with tumor progression in HCC [39], while POSTN (periostin) was reported as a marker for malignant transformation of hepatocytes [40]. The gene discussed is POSTN; the disease is cancer.